Patient perspectives: Lindsey MillerRebecca Aris interviews pancreatic neuroendocrine cancer patient Lindsey Miller on what it’s like to live with the disease Share XPatient perspectives: Lindsey Millerhttps://pharmaphorum.com/views-and-analysis/patient-perspective-lindsey-miller/
Cell line authentication: helping create a strong foundation for biopharmaceutical researchWith the proliferation of studies in the fast growing fields of personalized and regenerative medicine, it is essential Share XCell line authentication: helping create a strong foundation for biopharmaceutical researchhttps://pharmaphorum.com/views-and-analysis/cell-line-authentication-helping-create-a-strong-foundation-for-biopharmaceutical-research/
Why the iPad Matters for Healthcare IndustryAshish Khera takes a look into the rise of the iPad in pharmaceutical and healthcare sales and marketing. Share XWhy the iPad Matters for Healthcare Industryhttps://pharmaphorum.com/views-and-analysis/why-the-ipad-matters-for-healthcare-industry/
How NGS is changing the future of IVFpharmaphorum interviewed the University of Oxford’s Dr Dagan Wells following his recent acknowledgement for his work in using Share XHow NGS is changing the future of IVFhttps://pharmaphorum.com/views-and-analysis/how-ngs-is-changing-the-future-of-ivf/
Spotlight on… thyroid disease: hyperthyroidismThere are two main types of thyroid disease – in this article, Lyn Mynott explains all about hyperthyroidism, Share XSpotlight on… thyroid disease: hyperthyroidismhttps://pharmaphorum.com/views-and-analysis/spotlight-on-thyroid-disease-hyperthyroidism/
Intellectual property issues in personalised medicineIn our personalised medicine focus month, Katherine Bonter discusses the developments and challenges in personalised medicine relating to Share XIntellectual property issues in personalised medicinehttps://pharmaphorum.com/views-and-analysis/intellectual-property-issues-in-personalised-medicine/
Why PM 1.0 will not create radical healthcare change prompting the need for PM 2.0Peter Keeling explores the concept of personalised medicine 2.0 in our personalised medicine themed month. The six forces Share XWhy PM 1.0 will not create radical healthcare change prompting the need for PM 2.0https://pharmaphorum.com/views-and-analysis/why-pm-1-0-will-not-create-radical-healthcare-change-prompting-the-need-for-pm-2-0/
The Art of War GamesThe industry’s transition from the commercial to the competitive lifecycle stage compels companies to adopt a totally different Share XThe Art of War Gameshttps://pharmaphorum.com/views-and-analysis/the-art-of-war-games/
To what degree do you need them?Robin Winter-Sperry highlights the challenges in recruiting the right candidate for a role in Medical Affairs. When a Share XTo what degree do you need them?https://pharmaphorum.com/views-and-analysis/to-what-degree-do-you-need-them/
